|
List of Jounal Titles
A to Z index of Journal Title. Choose a letter.
Japanese Journal of Chemotherapy
50
- In vitro activity of a new lipopeptide antifungal agent, micafungin against a variety of clinically important fungi.
- Anti-fungal mechanisms of micafungin: Enzymological and morphological studies of micafungin action against Candida albicans and Aspergillus fumigatus.
- Efficacy of micafungin, a newlipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.
- Efficacy of micafungin, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis.
- Minimum effective concentrations of micafungin for the treatment of disseminated Candida albicans infection and pulmonary Aspergillus fumigatus infection in the mouse.
- Therapeutic effect of micafungin on oropharyngeal candidiasis in congenitally immunodeficient mice.
- Antifungal activities of the M 1, M 2 and M 5 metabolites of micafungin.
- Combination effect of micafungin with amphotericin B, itraconazole and fluconazole.
- Simultaneous determination of antifungal drug, micafungin, and its two active metabolites in human plasma using high-performance liquid chromatography with fluorescence detection.
- Pharmacokinetics of the antifungal drug micafungin in mice, rats and dogs, and its in vitro protein binding and distribution to blood cells.
- Distribution and excretion after intravenous dosing of [14C]micafungin to rats.
- Metabolites of micafungin in rats and dogs.
- Drug interactions of micafungin in vitro.
- Phase I study of micafungin.
- Pharmacokinetic study of micafungin in elderly subjects.
- Pharmacokinetic study of micagungin.
1
- Comparison of in vitro activity of biapenem with other antimicrobial agents against clinical isolates of Pseudomonas aeruginosa.
- In vitro activities of telithromycin against macroride-resistant oral streptococci.
- PCR detection of .BETA.-lactamase genes in Prevotella spp.: Based on analysis of Prevotella nigrescens TO167 carbapenemase gene.
- In vitro and in vivo antibacterial activity of cefteram pivoxil against cephem-resistant Escherichia coli.
- Clinical efficacy of cefepime in nonresponders to other antibiotics of postmarketing special surveillance.
2
- Early postmarketing phase vigilance(EPPV) for new drugs.
- Surveillance of clinical isolate sensitivity to cefepime.
- Antibacterial and bactericidal activity of EGCg on Streptococcus pneumoniae.
- Antibacterial activity of prulifloxacin against antibacterial drug resistant clinical isolates.
- Epidemiology of extended-spectrum beta-lactamase producing Enterobacteriaceae excluding Escherichia coli and Klebsiella spp. isolated from 6 hospitals in Kinki, Japan.
- Mutation of penicillin-binding protein genes and antimicrobial susceptibility ofStreptococcus pneumoniae isolated from liquor or blood in children.
3
- Activity of biapenem and 7 other antimicrobial agents against Streptococcus pneumoniae.
- Investigation on compliance of oral medicine in patients with uterine cervicitis caused by Chlamydia trachomatis.
- Comparison of approaches in teicoplanin therapeutic drug monitoring.
- Antimicrobial susceptibility of clinical isolates of Streptococcus pneumoniae from pediatric patients in the Republic of Korea and Japan.
- Recurrent adrenocortical carcinoma with tumor reduction using mitotane (o,p'-DDD): A case report.
- A case of teicoplanin medication in reinfected methicillin-resistant Staphylococcus aureus osteomyelitis.
4
- In vitro anti-Legionella pneumophila activity of tosufloxacin and its therapeutic effect on experimental Legionella pneumonia in guinea pigs.
- Cases were isolated of VRE in the northern Kyushu and antibacterial activity of linezolid and other drugs against bacterial strains encoding vanA, vanB, vanC genotype.
- Safety and pharmacokinetics of palivizumab, administered in infants with a history of prematurity or chronic lung disease.
- A clinical study on levofloxacin concentration in the skin on antibiotic prophylaxis for outpatient surgery.
- Intravesical therapy of pirarubicin (THP) against bladder cancer: Penetration of THP into bladder cancer tissue and its prophylactic effect against intravesical recurrence of bladder cancer after transurethral resection.
- Transparent, opaque and rough colonial variant susceptibility of Mycobacterium intracellulare to antimicrobial drugs.
5
- Pathologic morphology of infectious disease.
- Evaluation of antimicrobial activity of .BETA.-lactam antibiotics by Etest against clinical isolates.
- Evaluation of bactericidal effect of injectable antibacterial agents in polimicrobial infection using a rat granuloma pouch infection model.
- Bactericidal activity of pazufloxacin mesilate against Pseudomonas aeruginosa and MRSA in an in vitro dynamic model.
- Clinical evaluation of injectable ciprofloxacin in poor responders to carbapenems and injectable third-generation cephems.
- A case of lung adenocarcinoma was successfully treated with combination therapy of platinum anticancer drugs and paclitaxel.
- Altered susceptibilties of Mycobacterium tuberculosis and Mycobacterium avium complex to rifalazil, clarithromycin, and levofloxacin after adaptation to intramacrophage millieus as determined by intracellular susceptibility testing.
6
- Policy of perioperative antimicrobial administration.
- Bactericidal activity of levofloxacin and cefcapene against Haemophilus influenzae.
- Influence of ceftizoxime alapivoxil on intestinal bacterial flora: A study in gnotobiotic mice inoculated with 4 bacterial strains.
- Annual changes in susceptibility of clinical isolates to biapenem.
- Changes in nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae from amoxicillin and cefditoren-pivoxil therapy in children with acute otitis media.
- Accuracy assessment of vancomycin serum concentrations predicted by population pharmacokinetic parameters and the Bayesian method.
7
- Socioeconomic Changes, Standardization of Medical Practices and Prognosis.
- Therapeutic effect of .BETA.-lactam antibiotics on murine streptococcal pneumonia. Relationship between MICs and therapeutic efficacies.
- Basic and clinical studies on the usefulness of levofloxacin in respiratory infections.
- Clinical analysis of combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for patients with pneumonia.
- Optimal clinical dose of pazufloxacin mesilate in respiratory tract infection or complicated urinary tract infection.
- Convulsant activity of norfloxacin and gatifloxacin and interaction with antiinflammatory drugs.
8
- Antichlamydial activity of tosufloxacin in each stage of the chlamydial life cycle.
- Epidemiological survey of drug resistance of methicillin-resistant Staphylococcus aureus isolated in Japan in 2000.
- Evaluation of the antimicrobial activity of .BETA.-lactam antibiotics by Etest against clinical isolates.
- In vitro and in vivo combination effects of cefditoren and fosfomycin against penicillin-resistant Streptococcus pneumoniae.
- Efficacy of 400 mg of levofloxacin twice a day orally in community-acquired pneumonia.
- Respiratory tract infection-Pneumonia.
- Evaluation of antibiotics for the indication of septicemia; In search of better guidelines.
- Pharmacoeconomic research status and issues in clinical development of antimicrobial agents. Results of a questionnaire targeting leading clinical physicians belonging to the Japanese Society of Chemotherapy and pharmaceutical companies.
9
- Present and Future of Anti-bacterial and Anti-fungal Chemotherapy.
10
- Antimicrobial agents against vancomycin-resistant enterococci (Linezolid).
- A study on the pharmacokinetics and safety of faropenem sodium in elderly patients.
- Clinical studies of gatifloxacin for infections in internal medicine.
- Clinical studies of gatifloxacin for infections in the surgical field.
- Clinical studies of gatifloxacin, a new fluoroquinolone, in genitourinary tract infections.
- Safety evaluation of gatifloxacin, a new fluoroquinolone.
- Adverse effects of cefoselis on the central nervous system: Identification of risk factors and estimation of incidence.
11
- Current status in the development of new antituberculosis drugs.
- Susceptibility and analysis of resistance to .BETA.-lactum agents of Enterobacteriaceae detected in blood cultures.
- Susceptibility testing isepamicin for gram-negative rod resistance to .BETA.-lactams isolated from blood.
- Surveillance based on molecular epidemiology for Haemophilus influenzae isolates between 1998 and 2000 in Japan. Results of clinical isolates collected by the Community-Acquired Bacterial Infections Working Group.
- Clinical and bacteriological study in children with Yersinia enterocolitica infection.
- Faropenem: A postmarketing surveillance review of 19,375 cases.
- Evaluation of a Bayesian method using a 1-point trough level for predicting individual vancomycin serum concentrations.
12
- A newclass of antifungal agent Candins.
- Effects of ATP on the in vitro and in vivo antimicrobial activity of murine macrophages against Mycobacterium avium complex.
- Surveillance of susceptibility to antibacterial agents of Streptococcus pneumoniae isolated from middle-ear acute otitis media in infants and children.
- Antimicrobial prophylaxis for transrectal prostatic biopsy: A prospective randomized trial using levofloxacin.
- Faropenem dry syrup for pediatric: A postmarketing surveillance safety review of 3,823 cases.
Supplement-1
| Copyright (c) 2006-2007 Japan Science and Technology Agency. All Rights Reserved. | |
